Showing results (61-70 of 115) with videos related to
Sort By:
Pageof 12
Clinical and Experimental Medicine|September 11, 2015
Hyaluronic acid concentration in liver diseasesMonika Gudowska, Ewa Gruszewska, Anatol Panasiuk, et al.Annals of Clinical and Laboratory Science|December 15, 2015
Galectin-3 Concentration in Liver DiseasesMonika Gudowska, Ewa Gruszewska, Bogdan Cylwik, et al.Journal of Clinical Medicine|April 27, 2024
The Association of Serum Profile of Transferrin Isoforms with COVID-19 Disease SeverityLech Chrostek, Kacper Gan, Marcin Kazberuk, et al.Przeglad Gastroenterologiczny|November 11, 2017
High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseasesMonika Gudowska, Ewa Gruszewska, Anatol Panasiuk, et al.Clinical Laboratory|February 10, 2017
Changed Profile of Serum Transferrin Isoforms in Liver DiseasesMonika Gudowska, Ewa Gruszewska, Anatol Panasiuk, et al.Laboratory Medicine|December 31, 2015
Selected Noninvasive Markers in Diagnosing Liver DiseasesMonika Gudowska, Ewa Gruszewska, Anatol Panasiuk, et al.International Journal of Molecular Sciences|May 27, 2026
Diagnostic Usefulness of SP-D, CCL2/MCP-1, and IL-18 in Assessing Respiratory Function and Risk of Pulmonary Fibrosis in COVID-19 PatientsBogdan Cylwik, Kacper Gan, Marcin Kazberuk, et al.Clinical Biochemistry|July 5, 2017
The transferrin isoforms in chronic hepatitisEwa Gruszewska, Alicja Wrona, Monika Gudowska, et al.Journal of Clinical Medicine|September 10, 2021
Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis CDagmara Przekop, Jakub Klapaczynski, Agnieszka Grytczuk, et al.Clinical and Experimental Hepatology|September 1, 2017
Simple non-invasive markers for early diagnosis and determination of the severity of liver diseasesMonika Gudowska, Alicja Wrona, Ewa Gruszewska, et al.Pageof 12